<DOC>
	<DOCNO>NCT00920725</DOCNO>
	<brief_summary>The purpose study determine whether insulin administer subcutaneous injection effective treatment diabetic crisis determine beta-hydroxybutyrate useful monitor treatment diabetic crisis .</brief_summary>
	<brief_title>Subcutaneous Aspart Insulin Treat Diabetic Ketoacidosis ( DKA ) Beta-Hydroxybutyrate Testing DKA</brief_title>
	<detailed_description />
	<mesh_term>Ketosis</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Diabetic Ketoacidosis</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>age 18 old venous pH &lt; 7.3 arterial &lt; 7.35 least 2 follow 3 : 1. serum HCO3 &lt; 18/anion gap &gt; 16 2. serum glucose &gt; 300 mg/dl 3. serum acetone positive pregnant less age 18</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>DKA</keyword>
</DOC>